(Q33631372)

English

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

Thomas Pfammatter

9

object named as

Thomas Pfammatter

0 references

1 reference

ORCID Public Data File 2021

4

object named as

Frank Pilleul

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Johannes Lammer

1

object named as

Johannes Lammer

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Katarina Malagari

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Thomas Vogl

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Alban Denys

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Anthony Watkinson

6

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Michael Pitton

7

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Geraldine Sergent

8

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Thomas Pfammatter

9

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Sylvain Terraz

10

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Yves Benhamou

11

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Yves Avajon

12

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Thomas Gruenberger

13

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Maria Pomoni

14

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Herbert Langenberger

15

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Marcus Schuchmann

16

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Jerome Dumortier

17

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Christian Mueller

18

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Patrick Chevallier

19

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Riccardo Lencioni

20

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PRECISION V Investigators

21

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

12 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

CardioVascular and Interventional Radiology

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

41-52

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

21 June 2018

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

21 June 2018

Design and endpoints of clinical trials in hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

21 June 2018

Transcatheter arterial chemoembolization (TACE) with lipiodol to treat hepatocellular carcinoma: survey results from the TACE study group of Japan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

21 June 2018

Drug-loaded microspheres for the treatment of liver cancer: review of current results.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

21 June 2018

Hepatocellular carcinoma: the role of the North American GI Steering Committee Hepatobiliary Task Force and the advent of effective drug therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

21 June 2018

Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

21 June 2018

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

21 June 2018

DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

21 June 2018

Management of hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

21 June 2018

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

21 June 2018

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

21 June 2018

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

21 June 2018

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

21 June 2018

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

21 June 2018

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

21 June 2018

Prognosis of hepatocellular carcinoma: the BCLC staging classification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

21 June 2018

Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

21 June 2018

Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

21 June 2018

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

21 June 2018

Approximately optimal one-parameter boundaries for group sequential trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

21 June 2018

Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma--a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

21 June 2018

Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres: preliminary results from an Italian multicentre study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

30 October 2018

Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

30 October 2018

Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

30 October 2018

A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

30 October 2018

Doxorubicin eluting beads - 1: effects of drug loading on bead characteristics and drug distribution

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

30 October 2018

Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

30 October 2018

Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

30 October 2018

New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816794

30 October 2018

Chemoembolization of hepatocellular carcinomas. A study of the biodistribution and pharmacokinetics of doxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/19908093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC

1 reference

https://pubmed.ncbi.nlm.nih.gov/19908093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CONSORT for reporting randomised trials in journal and conference abstracts

1 reference

https://pubmed.ncbi.nlm.nih.gov/19908093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00270-009-9711-7

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Dimensions Publication ID

0 references

release_dfdjvwzu3jcdtg4pldfthyqinu

1 reference

https://api.fatcat.wiki/v0/release/dfdjvwzu3jcdtg4pldfthyqinu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33631372&oldid=2195590998"